Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
about
Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis.Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceUsefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
P2860
Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical implications of assay ...... el disease activity over time.
@en
type
label
Clinical implications of assay ...... el disease activity over time.
@en
prefLabel
Clinical implications of assay ...... el disease activity over time.
@en
P2093
P2860
P1476
Clinical implications of assay ...... el disease activity over time.
@en
P2093
Anders Magnuson
Jonas Halfvarson
Karin Amcoff
Marie Carlson
Mats Stridsberg
P2860
P304
P356
10.1080/00365521.2016.1256424
P50
P577
2016-11-24T00:00:00Z